SETD1A and hepatocellular carcinoma: Here, we established a genome-wide CRISPR knockout screening in CD24+CD133+ liver CSCs and identified the H3K4 methyltransferase SET domain containing 1A (SETD1A) as a critical diver for HCC stemness and progression, providing a therapeutic target for HCC treatment.